Goldman Sachs’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.8M Sell
1,301,381
-360,658
-22% -$4.09M ﹤0.01% 1980
2025
Q1
$11.1M Buy
1,662,039
+293,072
+21% +$1.95M ﹤0.01% 2158
2024
Q4
$15.1M Sell
1,368,967
-24,793
-2% -$273K ﹤0.01% 2014
2024
Q3
$17.1M Buy
1,393,760
+26,243
+2% +$323K ﹤0.01% 1845
2024
Q2
$18.5M Sell
1,367,517
-36,538
-3% -$494K ﹤0.01% 1646
2024
Q1
$19M Buy
1,404,055
+12,624
+0.9% +$170K ﹤0.01% 1585
2023
Q4
$7.32M Buy
1,391,431
+1,262,126
+976% +$6.64M ﹤0.01% 2306
2023
Q3
$509K Buy
129,305
+35,804
+38% +$141K ﹤0.01% 3886
2023
Q2
$994K Buy
93,501
+11,329
+14% +$120K ﹤0.01% 3610
2023
Q1
$684K Buy
82,172
+14,310
+21% +$119K ﹤0.01% 3902
2022
Q4
$626K Sell
67,862
-44,404
-40% -$410K ﹤0.01% 3963
2022
Q3
$1.44M Sell
112,266
-9,521
-8% -$122K ﹤0.01% 3586
2022
Q2
$1.61M Buy
121,787
+7,745
+7% +$102K ﹤0.01% 3608
2022
Q1
$2.4M Sell
114,042
-12,289
-10% -$259K ﹤0.01% 3443
2021
Q4
$3.03M Sell
126,331
-46,418
-27% -$1.11M ﹤0.01% 3182
2021
Q3
$4.4M Buy
172,749
+36,361
+27% +$925K ﹤0.01% 2880
2021
Q2
$4.59M Sell
136,388
-421,985
-76% -$14.2M ﹤0.01% 2845
2021
Q1
$21.7M Sell
558,373
-18,597
-3% -$722K 0.01% 1626
2020
Q4
$35.7M Buy
576,970
+468,466
+432% +$29M 0.01% 1181
2020
Q3
$3.63M Sell
108,504
-34,680
-24% -$1.16M ﹤0.01% 2576
2020
Q2
$3.41M Buy
143,184
+122,228
+583% +$2.91M ﹤0.01% 2545
2020
Q1
$480K Sell
20,956
-47,017
-69% -$1.08M ﹤0.01% 3520
2019
Q4
$1.93M Buy
67,973
+21,786
+47% +$617K ﹤0.01% 2962
2019
Q3
$993K Sell
46,187
-33,475
-42% -$720K ﹤0.01% 3257
2019
Q2
$2.32M Buy
+79,662
New +$2.32M ﹤0.01% 2727